Showing results (391-400 of 439) with videos related to
Sort By:
Pageof 44
World Neurosurgery|August 28, 2020
Intracranial Tumor Control After Immune-Related Adverse Events and Discontinuation of Immunotherapy for MelanomaMichael Zhang, Adrian J Rodrigues, Hriday P Bhambhvani, et al.Blood|July 10, 1998
Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemiaC H Pui, H H Mahmoud, G K Rivera, et al.Journal of Neurosurgery. Spine|March 2, 2020
Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal originNavjot Sandhu, Kathryn R K Benson, Kiran A Kumar, et al.Practical Radiation Oncology|May 20, 2020
Stereotactic Radiosurgery for Resected Brain Metastases: Does the Surgical Corridor Need to be Targeted?Siyu Shi, Navjot Sandhu, Michael Jin, et al.Ecology and Evolution|November 22, 2012
Gene flow on ice: the role of sea ice and whaling in shaping Holarctic genetic diversity and population differentiation in bowhead whales (Balaena mysticetus)S Elizabeth Alter, Howard C Rosenbaum, Lianne D Postma, et al.Journal of Neuro-Oncology|January 8, 2021
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastasesMichael Zhang, Adrian J Rodrigues, Erqi L Pollom, et al.Leukemia|March 21, 2003
Urolithiasis in pediatric patients with acute lymphoblastic leukemiaS C Howard, S D Kaplan, B I Razzouk, et al.International Journal of Radiation Oncology, Biology, Physics|December 1, 2019
Stereotactic Radiosurgery for Resected Brain Metastases: Single-Institutional Experience of Over 500 CavitiesSiyu Shi, Navjot Sandhu, Michael C Jin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significanceJ E Rubnitz, J R Downing, C H Pui, et al.European Urology|June 28, 2014
Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancerEvan Y Yu, Robert H Getzenberg, Christopher C Coss, et al.Pageof 44